News
CRISPR Therapeutics partnered with big biotech Vertex Pharmaceuticals ( VRTX 3.40%) on Casgevy. Although Vertex takes a ...
Amid a shaky macroeconomic backdrop, biotech stocks have underperformed, with XBI showing poor technical momentum and ...
Former New Hampshire Gov. Chris Sununu (R) said Sunday that the Trump administration has “about six weeks” when it comes to a ...
With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.
A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...
The incarcerated former Silicon Valley star is advising her partner on a new health tech startup. Holmes was convicted of ...
Cost of License and Other Revenue: Cost of license and other revenue was $1.8 million for the three months ended March 31, ...
We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...
Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...
An appeals court has opened another chapter in the long-running CRISPR patent saga. | An appeals court has opened another ...
We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results